SCA
WST icon

Summit Creek Advisors’s West Pharmaceutical WST Stock Holding History

Summit Creek Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$463K Hold
1,290
– – 0.16% 55
2026
Q1 		$323K Buy
1,290
+324
+34% +$80.6K 0.07% 57
2025
Q4 		$266K Hold
966
– – 0.04% 62
2025
Q3 		$253K Sell
966
-66
-6% -$16K 0.04% 67
2025
Q2 		$226K Hold
1,032
– – 0.03% 68
2025
Q1 		$231K Buy
1,032
+5
+0.5% +$1.38K 0.03% 66
2024
Q4 		$336K Hold
1,027
– – 0.04% 62
2024
Q3 		$308K Sell
1,027
-66
-6% -$20.2K 0.04% 67
2024
Q2 		$360K Hold
1,093
– – 0.05% 60
2024
Q1 		$433K Buy
1,093
+14
+1% +$5.18K 0.05% 59
2023
Q4 		$380K Hold
1,079
– – 0.05% 58
2023
Q3 		$405K Hold
1,079
– – 0.06% 58
2023
Q2 		$413K Buy
1,079
+1
+0.1% +$357 0.05% 60
2023
Q1 		$373K Hold
1,078
– – 0.05% 61
2022
Q4 		$254K Buy
1,078
+9
+0.8% +$2.13K 0.03% 68
2022
Q3 		$263K Sell
1,069
-767
-42% -$234K 0.04% 66
2022
Q2 		$555K Buy
1,836
+28
+2% +$9.11K 0.07% 64
2022
Q1 		$743K Buy
1,808
+10
+0.6% +$3.92K 0.08% 64
2021
Q4 		$843K Buy
1,798
+4
+0.2% +$1.72K 0.08% 64
2021
Q3 		$762K Buy
1,794
+450
+33% +$190K 0.08% 65
2021
Q2 		$483K Hold
1,344
– – 0.06% 62
2021
Q1 		$379K Buy
1,344
+374
+39% +$107K 0.05% 63
2020
Q4 		$275K Sell
970
-2,940
-75% -$825K 0.04% 64
2020
Q3 		$1.07M Hold
3,910
– – 0.16% 61
2020
Q2 		$888K Hold
3,910
– – 0.13% 62
2020
Q1 		$595K Hold
3,910
– – 0.12% 63
2019
Q4 		$588K Hold
3,910
– – 0.09% 62
2019
Q3 		$555K Buy
+3,910
New +$538K 0.09% 62

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Summit Creek Advisors's WST Position: Q2 2026 in Review

Summit Creek Advisors held its West Pharmaceutical (WST) position steady in Q2 2026 at 1,290 shares worth $463K. The position accounts for 0.16% of the portfolio, ranked #55.

Summit Creek Advisors first reported a position in WST in Q3 2019 and has held it in 28 quarters since. The position peaked at $1.07M in Q3 2020. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Summit Creek Advisors held 1,290 shares of West Pharmaceutical worth $463K as of Q2 2026.
  • Summit Creek Advisors left its West Pharmaceutical share count unchanged in Q2 2026.
  • West Pharmaceutical made up 0.16% of Summit Creek Advisors's portfolio in Q2 2026, its #55 holding.
  • Summit Creek Advisors first reported a position in West Pharmaceutical in Q3 2019 and has held it in 28 quarters since.
  • Summit Creek Advisors's West Pharmaceutical position peaked at $1.07M in Q3 2020.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Summit Creek Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.